NMR and mass spectra of the synthesized compounds S1 Experimental General aspects. All reactions were performed in an atmosphere of dry argon. All solvents were dried according to the standard protocols. 1 H and 19 F NMR spectra were recorded on a Bruker Avance-400 spectrometer operating at 400.13 MHz for 1 H NMR and 376.5 MHz for 19 F NMR. Chemical shifts (δ) were referenced to the residual solvent peak (CDCl3, 1 H: 7.26 ppm and (CD3)2CO, 1 H: 2.05 ppm) for 1 H, and external CFCl3 for 19 F. IR spectra were recorded on a Bruker FTIR spectrometer Tensor 37 in KBr tablets. The UVvis spectra were measured on a Carl Zeis Specord M 40 spectrophotometer in CH2Cl2 and acetone. The mass spectra were obtained using a VISION 2000 (MALDI) mass spectrometer; the most intense peaks are given for each compound. The identities of new compounds were verified by TLC on Sorbfil and Kieselgel 60 F254 (Merck) plates.
S2 84.5%) as a red-violet powder. UV-vis (CH2Cl2): λmax, nm (log ε) 422 (307.7), 550 (32.4). IR (KBr) νmax, cm −1 : 2920 (porphyrin СН), 2123 (N3). 1 H NMR (400.13 MHz, CDCl3) : 9.10 (s, 8H, β-pyrrole). 19 1128.015; found 1128.002. 5,10,15,20-Tetrakis(4-azido-2,3,5,6-tetrafluorophenyl)porphyrinato nickel (II) (3b) [4] :
Sodium azide (1.26 g, 19.4 mmol) was suspended in dry DMSO (20 mL) under an argon atmosphere and stirred for 15 min. To this suspension porphyrin 2b (1.0 g, 0.97 mmol) in dry DMF (200 mL) was added at room temperature and then the reaction mixture was heated for 6 h at 65-70 °C under argon. Then the reaction mixture (room temperature) was poured into water (250 mL) and extracted with CHCl3 (4 × 150 mL).The extracts were washed with water (2 × 250 mL), dried over Na2SO4, filtered and solvent was removed in vacuo. The residue was purified by column chromatography on silica gel using a CHCl3/ hexane mixture (2:1) as an eluent to give azido-substituted porphyrin 3b (790 mg, 72.4%) as a dark purple powder. UV-vis (CH2Cl2): λmax, nm (log ε) 418 (287.0), 552 (28.6). IR (KBr) νmax, cm -1 : 2923 (porphyrin СН), 2125 (N3). 1 5,10,15,20-Tetrakis[4-(4'-N-maleimidomethyl-1',2',3'-triazole-1'-yl) 
